Called the Coalition for Effective Diagnostics, the organization has called on lawmakers to pass legislation revamping diagnostics regulation, including oversight of LDTs.
The company said that gains in its Agilent CrossLab Group offset losses across its other two divisions as the company undertakes restructuring to grow as the market improves.
The story has been corrected to say that the firm is seeking regulatory clearance for its PanCystPro test, not FDA clearance as previously stated. NEW YORK – Startup company Amplified Sciences on ...